Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.

about

Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.

P2860

Q52881816-EF266D56-79DC-429A-8FE0-52118E16E991

P2860

Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.

Item

http://www.wikidata.org/entity/Q36310347

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@ast

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@en

type

Item

label

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@ast

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@en

prefLabel

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@ast

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@en

P1476

Very Long Term Stability of Mi ...... with Hematologic Malignancies.

@en

P2093

Bilal Mohty

http://www.w3.org/2001/XMLSchema#string

Eddy Roosnek

http://www.w3.org/2001/XMLSchema#string

Emmanuel Levrat

http://www.w3.org/2001/XMLSchema#string

Jean Villard

http://www.w3.org/2001/XMLSchema#string

Marc Ansari

http://www.w3.org/2001/XMLSchema#string

Stavroula Masouridi

http://www.w3.org/2001/XMLSchema#string

P2860

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia.

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience.

Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases

Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme.

Mixed chimerism in SCT: conflict or peaceful coexistence?

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival.

Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms.

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.

Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation.

P304

176526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/176526

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Yves Chalandon

Jakob R. Passweg

P577

2015-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284113471

http://www.w3.org/2001/XMLSchema#string

P698

26640712

http://www.w3.org/2001/XMLSchema#string

P932

4657082

http://www.w3.org/2001/XMLSchema#string

Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.

about

P2860

P2860

Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932